parkinsonsdisease
A recent study has uncovered a significant link between the brain chemical dopamine and our ability to understand and attribute mental states to ourselves and others, a process known as mentalizing. Conducted by researchers at the University of Birmingham, the study demonstrates that altering dopamine levels in the brain affects these mentalizing abilities. These findings are detailed in the journal PLOS Biology. The study was motivated by the observation that people with disorders characterized by dopamine dysfunction, such as Parkinson’s disease, Huntington’s disease, Tourette’s syndrome, an...
PsyPost (CA)
A recent study has uncovered a significant link between the brain chemical dopamine and our ability to understand and attribute mental states to ourselves and others, a process known as mentalizing. Conducted by researchers at the University of Birmingham, the study demonstrates that altering dopamine levels in the brain affects these mentalizing abilities. These findings are detailed in the journal PLOS Biology. The study was motivated by the observation that people with disorders characterized by dopamine dysfunction, such as Parkinson’s disease, Huntington’s disease, Tourette’s syndrome, an...
PsyPost (UK)
A recent study has uncovered a significant link between the brain chemical dopamine and our ability to understand and attribute mental states to ourselves and others, a process known as mentalizing. Conducted by researchers at the University of Birmingham, the study demonstrates that altering dopamine levels in the brain affects these mentalizing abilities. These findings are detailed in the journal PLOS Biology. The study was motivated by the observation that people with disorders characterized by dopamine dysfunction, such as Parkinson’s disease, Huntington’s disease, Tourette’s syndrome, an...
PsyPost
Visual hallucinations are a significant issue for many patients with Parkinson’s disease. A recent study published in the journal Brain reveals that these hallucinations are associated with a marked deficiency of cholinergic activity in specific regions of the brain, particularly the left ventral visual stream and the left superior temporal lobe. This research highlights the importance of cholinergic denervation in visual hallucinations, offering new insights into the underlying mechanisms and potential treatment options. Parkinson’s disease is commonly associated with motor symptoms, but non-...
PsyPost (CA)
Visual hallucinations are a significant issue for many patients with Parkinson’s disease. A recent study published in the journal Brain reveals that these hallucinations are associated with a marked deficiency of cholinergic activity in specific regions of the brain, particularly the left ventral visual stream and the left superior temporal lobe. This research highlights the importance of cholinergic denervation in visual hallucinations, offering new insights into the underlying mechanisms and potential treatment options. Parkinson’s disease is commonly associated with motor symptoms, but non-...
PsyPost
Visual hallucinations are a significant issue for many patients with Parkinson’s disease. A recent study published in the journal Brain reveals that these hallucinations are associated with a marked deficiency of cholinergic activity in specific regions of the brain, particularly the left ventral visual stream and the left superior temporal lobe. This research highlights the importance of cholinergic denervation in visual hallucinations, offering new insights into the underlying mechanisms and potential treatment options. Parkinson’s disease is commonly associated with motor symptoms, but non-...
PsyPost (UK)
A recent study reveals that people aged over 50 who develop anxiety are more than twice as likely to be diagnosed with Parkinson’s disease compared to those without anxiety. This finding, published in the British Journal of General Practice, highlights the potential role of anxiety as an early indicator of Parkinson’s, prompting further investigation into its implications for early diagnosis and treatment. Parkinson’s disease is the second most common neurodegenerative disorder globally, projected to affect over 14 million people by 2040 due to increasing life expectancy. Early detection is cr...
PsyPost (CA)
A recent study reveals that people aged over 50 who develop anxiety are more than twice as likely to be diagnosed with Parkinson’s disease compared to those without anxiety. This finding, published in the British Journal of General Practice, highlights the potential role of anxiety as an early indicator of Parkinson’s, prompting further investigation into its implications for early diagnosis and treatment. Parkinson’s disease is the second most common neurodegenerative disorder globally, projected to affect over 14 million people by 2040 due to increasing life expectancy. Early detection is cr...
PsyPost
A recent study reveals that people aged over 50 who develop anxiety are more than twice as likely to be diagnosed with Parkinson’s disease compared to those without anxiety. This finding, published in the British Journal of General Practice, highlights the potential role of anxiety as an early indicator of Parkinson’s, prompting further investigation into its implications for early diagnosis and treatment. Parkinson’s disease is the second most common neurodegenerative disorder globally, projected to affect over 14 million people by 2040 due to increasing life expectancy. Early detection is cr...
PsyPost (UK)
The neurotransmitter dopamine is commonly known for its role in brain networks regulating pleasure and reward. But many people with disorders that affect the dopamine system, such as Parkinson’s disease or schizophrenia, also struggle with social abilities. These include recognising or understanding the emotions and mental states of others, something scientists call the “theory of mind”. These social difficulties can significantly impact the social relationships and quality of life of those affected. However, it has remained unclear whether these challenges are directly caused by dopamine imba...
PsyPost (UK)
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら